Evidence map›Paper›PMID 42470561›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2026

Efficient Protocol for Doubled Haploid Production in Rye (Secale cereale L.).

Ewa Dubas, Monika Krzewska, Iwona Żur

Abstract read
PubMed Publisher
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Ewa DubasThe Franciszek Górski Institute of Plant Physiology, Polish Academy of Sciences, Kraków, Poland. e.dubas@ifr-pan.edu.pl.ORCID http://orcid.org/0000-0002-4908-4052
Monika KrzewskaThe Franciszek Górski Institute of Plant Physiology, Polish Academy of Sciences, Kraków, Poland.ORCID http://orcid.org/0000-0003-3563-4727
Iwona ŻurThe Franciszek Górski Institute of Plant Physiology, Polish Academy of Sciences, Kraków, Poland.ORCID http://orcid.org/0000-0002-2038-8554

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The cultivation of rye (Secale cereale L.) for functional foods is economically important due to its high-dietary fiber content and health-related bioactive compounds. Breeders are seeking modern biotechnology techniques to accelerate traditional breeding in this predominantly cross-pollinated species. The development of efficient protocols for double haploid (DH) production in rye breeding faces challenges. Despite five decades of research, no universally efficient DH production protocol has emerged, largely due to genotypic variability and recalcitrance to in vitro regeneration. The protocols presented here incorporate antioxidants, such as reduced glutathione (GSH) and selenium (SS), into the tiller low temperature pretreatment procedure, as well as arabinogalactan proteins (AGPs) and phytagel into the induction medium. All these modifications aim to reduce the generation of reactive oxygen species (ROS). As a result, microspores are more likely to survive stress pretreatment, the isolation process and transfer to in vitro culture better. A higher population of viable microspores could result in an increase in the number of reprogrammed, embryogenic microspores and microspore-derived embryo-like structures (ELS). The protocols presented have been tested on 15 F1 rye breeding lines, with the greatest effectiveness in lines with moderate and high responsiveness to androgenesis induction, also known as microspore embryogenesis (ME) induction.

Indexed as

HaploidyPlant BreedingSecaleAntioxidantsAntioxidantsIn vitro cultureMannitolMicrospore embryogenesisReduced glutathioneRyeSeleniumStress pretreatment

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.